Stocks
Evolus, Inc.EOLS
NASDAQHealthcareBiotechnology$7.01
Price as of · delayed, not real-time
A medical aesthetics company focused on developing and commercializing botulinum toxin type A products for aesthetic and therapeutic uses. Its lead product, Jeuveau, competes directly with established neuromodulators in the U.S. market, and investors track the company for its growth trajectory in the facial aesthetics segment.
52W Range: $3.86-$9.31
Congressional Interest in Evolus, Inc. (EOLS)
No congressional trades have been disclosed for Evolus, Inc. (EOLS) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading EOLS?
No congressional trades found for this stock.